Anti-Sars-Cov-2 IgA And IgG In Human Milk After Vaccination Is Dependent On Vaccine Type And Previous Sars-Cov-2 Exposure: A Longitudinal Study
Importance Limited data are available on COVID-19 vaccine impact in lactating women. Objective To evaluate the impact of different COVID-19 vaccines on specific anti-SARS-CoV-2 IgA and IgG levels in human milk. Design, Settings and Participants In this prospective observational study in Spain, 75 lactating women from priority groups receiving vaccination against SARS-CoV-2 were included (January to April 2021). Human milk samples were collected at seven-time points. A group with confirmed SARS-CoV-2 infection (n=19) and a group of women from prepandemic time (n=13) were included. Exposure mRNA vaccines (BNT162b2 and mRNA-1273) and adenovirus-vectored vaccine (ChAdOx1 nCoV-19). Main Outcome(s) and Measure(s) Presence of IgA and IgG against RBD SARS-CoV-2 in breast milk. Results Seventy-five vaccinated lactating women [mean age, 34.9 ± 3.7 years] of whom 96% were Caucasic and 92% were health care workers. A total of 417 milk samples were included and vaccine distribution was BioNTech/Pfizer (BNT162b2, n=30), Moderna (mRNA-1273, n=21), and AstraZeneca (ChAdOx1 nCoV-19, n=24). For each vaccine, 7 time points were collected from baseline up to 25 days after the 1st dose and same points were collected for mRNA vaccines 30 days after 2nd dose. A strong reactivity was observed for IgG and IgA after vaccination mainly after the 2nd dose. Presence and the persistence of specific SARS-CoV-2 antibodies in breast milk were dependent on the vaccine-type and, on previous virus exposure. High inter-variability was observed, being relevant for IgA antibodies. IgG levels were significantly higher than those observed in milk from COVID-19 women while IgA levels were lower. Women with previous COVID-19 increased the IgG levels after the 1st dose to a similar level observed in vaccinated women after the 2nd dose. Conclusions and Relevance Breast milk from vaccinated women contains anti-SARS-CoV-2 IgA and IgG, with highest after the 2nd dose. Levels were dependent on vaccine type and previous exposure to SARS-CoV-2. Previous COVID-19 influenced the vaccine effect after a single dose, which could be especially relevant in the design of vaccination protocols. Further studies are warranted to demonstrate the potential protective role of these antibodies against COVID-19 in infants from vaccinated and infected mothers through breastfeeding.
Main Authors: | , , , , , , , , |
---|---|
Other Authors: | |
Format: | preprint biblioteca |
Language: | English |
Published: |
MedRxiv
2021-05-23
|
Online Access: | http://hdl.handle.net/10261/242947 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
dig-iata-es-10261-242947 |
---|---|
record_format |
koha |
spelling |
dig-iata-es-10261-2429472021-06-09T01:20:04Z Anti-Sars-Cov-2 IgA And IgG In Human Milk After Vaccination Is Dependent On Vaccine Type And Previous Sars-Cov-2 Exposure: A Longitudinal Study Selma Royo, Marta Bäuerl, Christine Mena-Tudela, Desirée Aguilar-Camprubí, Laia Pérez-Cano, Francisco J. Parra-Llorca, Anna Lerin, Carles Martínez-Costa, Cecilia Collado, María Carmen Collado, María Carmen [0000-0002-6204-4864] Importance Limited data are available on COVID-19 vaccine impact in lactating women. Objective To evaluate the impact of different COVID-19 vaccines on specific anti-SARS-CoV-2 IgA and IgG levels in human milk. Design, Settings and Participants In this prospective observational study in Spain, 75 lactating women from priority groups receiving vaccination against SARS-CoV-2 were included (January to April 2021). Human milk samples were collected at seven-time points. A group with confirmed SARS-CoV-2 infection (n=19) and a group of women from prepandemic time (n=13) were included. Exposure mRNA vaccines (BNT162b2 and mRNA-1273) and adenovirus-vectored vaccine (ChAdOx1 nCoV-19). Main Outcome(s) and Measure(s) Presence of IgA and IgG against RBD SARS-CoV-2 in breast milk. Results Seventy-five vaccinated lactating women [mean age, 34.9 ± 3.7 years] of whom 96% were Caucasic and 92% were health care workers. A total of 417 milk samples were included and vaccine distribution was BioNTech/Pfizer (BNT162b2, n=30), Moderna (mRNA-1273, n=21), and AstraZeneca (ChAdOx1 nCoV-19, n=24). For each vaccine, 7 time points were collected from baseline up to 25 days after the 1st dose and same points were collected for mRNA vaccines 30 days after 2nd dose. A strong reactivity was observed for IgG and IgA after vaccination mainly after the 2nd dose. Presence and the persistence of specific SARS-CoV-2 antibodies in breast milk were dependent on the vaccine-type and, on previous virus exposure. High inter-variability was observed, being relevant for IgA antibodies. IgG levels were significantly higher than those observed in milk from COVID-19 women while IgA levels were lower. Women with previous COVID-19 increased the IgG levels after the 1st dose to a similar level observed in vaccinated women after the 2nd dose. Conclusions and Relevance Breast milk from vaccinated women contains anti-SARS-CoV-2 IgA and IgG, with highest after the 2nd dose. Levels were dependent on vaccine type and previous exposure to SARS-CoV-2. Previous COVID-19 influenced the vaccine effect after a single dose, which could be especially relevant in the design of vaccination protocols. Further studies are warranted to demonstrate the potential protective role of these antibodies against COVID-19 in infants from vaccinated and infected mothers through breastfeeding. Peer reviewed 2021-06-08T14:16:21Z 2021-06-08T14:16:21Z 2021-05-23 preprint http://purl.org/coar/resource_type/c_816b MedRxiv: 10.1101/2021.05.20.21257512 (2021) http://hdl.handle.net/10261/242947 10.1101/2021.05.20.21257512 en https://doi.org/10.1101/2021.05.20.21257512 Sí open MedRxiv |
institution |
IATA ES |
collection |
DSpace |
country |
España |
countrycode |
ES |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-iata-es |
tag |
biblioteca |
region |
Europa del Sur |
libraryname |
Biblioteca del IATA España |
language |
English |
description |
Importance Limited data are available on COVID-19 vaccine impact in lactating women.
Objective To evaluate the impact of different COVID-19 vaccines on specific anti-SARS-CoV-2 IgA and IgG levels in human milk.
Design, Settings and Participants In this prospective observational study in Spain, 75 lactating women from priority groups receiving vaccination against SARS-CoV-2 were included (January to April 2021). Human milk samples were collected at seven-time points. A group with confirmed SARS-CoV-2 infection (n=19) and a group of women from prepandemic time (n=13) were included.
Exposure mRNA vaccines (BNT162b2 and mRNA-1273) and adenovirus-vectored vaccine (ChAdOx1 nCoV-19).
Main Outcome(s) and Measure(s) Presence of IgA and IgG against RBD SARS-CoV-2 in breast milk.
Results Seventy-five vaccinated lactating women [mean age, 34.9 ± 3.7 years] of whom 96% were Caucasic and 92% were health care workers. A total of 417 milk samples were included and vaccine distribution was BioNTech/Pfizer (BNT162b2, n=30), Moderna (mRNA-1273, n=21), and AstraZeneca (ChAdOx1 nCoV-19, n=24). For each vaccine, 7 time points were collected from baseline up to 25 days after the 1st dose and same points were collected for mRNA vaccines 30 days after 2nd dose. A strong reactivity was observed for IgG and IgA after vaccination mainly after the 2nd dose. Presence and the persistence of specific SARS-CoV-2 antibodies in breast milk were dependent on the vaccine-type and, on previous virus exposure. High inter-variability was observed, being relevant for IgA antibodies. IgG levels were significantly higher than those observed in milk from COVID-19 women while IgA levels were lower. Women with previous COVID-19 increased the IgG levels after the 1st dose to a similar level observed in vaccinated women after the 2nd dose.
Conclusions and Relevance Breast milk from vaccinated women contains anti-SARS-CoV-2 IgA and IgG, with highest after the 2nd dose. Levels were dependent on vaccine type and previous exposure to SARS-CoV-2. Previous COVID-19 influenced the vaccine effect after a single dose, which could be especially relevant in the design of vaccination protocols. Further studies are warranted to demonstrate the potential protective role of these antibodies against COVID-19 in infants from vaccinated and infected mothers through breastfeeding. |
author2 |
Collado, María Carmen [0000-0002-6204-4864] |
author_facet |
Collado, María Carmen [0000-0002-6204-4864] Selma Royo, Marta Bäuerl, Christine Mena-Tudela, Desirée Aguilar-Camprubí, Laia Pérez-Cano, Francisco J. Parra-Llorca, Anna Lerin, Carles Martínez-Costa, Cecilia Collado, María Carmen |
format |
preprint |
author |
Selma Royo, Marta Bäuerl, Christine Mena-Tudela, Desirée Aguilar-Camprubí, Laia Pérez-Cano, Francisco J. Parra-Llorca, Anna Lerin, Carles Martínez-Costa, Cecilia Collado, María Carmen |
spellingShingle |
Selma Royo, Marta Bäuerl, Christine Mena-Tudela, Desirée Aguilar-Camprubí, Laia Pérez-Cano, Francisco J. Parra-Llorca, Anna Lerin, Carles Martínez-Costa, Cecilia Collado, María Carmen Anti-Sars-Cov-2 IgA And IgG In Human Milk After Vaccination Is Dependent On Vaccine Type And Previous Sars-Cov-2 Exposure: A Longitudinal Study |
author_sort |
Selma Royo, Marta |
title |
Anti-Sars-Cov-2 IgA And IgG In Human Milk After Vaccination Is Dependent On Vaccine Type And Previous Sars-Cov-2 Exposure: A Longitudinal Study |
title_short |
Anti-Sars-Cov-2 IgA And IgG In Human Milk After Vaccination Is Dependent On Vaccine Type And Previous Sars-Cov-2 Exposure: A Longitudinal Study |
title_full |
Anti-Sars-Cov-2 IgA And IgG In Human Milk After Vaccination Is Dependent On Vaccine Type And Previous Sars-Cov-2 Exposure: A Longitudinal Study |
title_fullStr |
Anti-Sars-Cov-2 IgA And IgG In Human Milk After Vaccination Is Dependent On Vaccine Type And Previous Sars-Cov-2 Exposure: A Longitudinal Study |
title_full_unstemmed |
Anti-Sars-Cov-2 IgA And IgG In Human Milk After Vaccination Is Dependent On Vaccine Type And Previous Sars-Cov-2 Exposure: A Longitudinal Study |
title_sort |
anti-sars-cov-2 iga and igg in human milk after vaccination is dependent on vaccine type and previous sars-cov-2 exposure: a longitudinal study |
publisher |
MedRxiv |
publishDate |
2021-05-23 |
url |
http://hdl.handle.net/10261/242947 |
work_keys_str_mv |
AT selmaroyomarta antisarscov2igaandigginhumanmilkaftervaccinationisdependentonvaccinetypeandprevioussarscov2exposurealongitudinalstudy AT bauerlchristine antisarscov2igaandigginhumanmilkaftervaccinationisdependentonvaccinetypeandprevioussarscov2exposurealongitudinalstudy AT menatudeladesiree antisarscov2igaandigginhumanmilkaftervaccinationisdependentonvaccinetypeandprevioussarscov2exposurealongitudinalstudy AT aguilarcamprubilaia antisarscov2igaandigginhumanmilkaftervaccinationisdependentonvaccinetypeandprevioussarscov2exposurealongitudinalstudy AT perezcanofranciscoj antisarscov2igaandigginhumanmilkaftervaccinationisdependentonvaccinetypeandprevioussarscov2exposurealongitudinalstudy AT parrallorcaanna antisarscov2igaandigginhumanmilkaftervaccinationisdependentonvaccinetypeandprevioussarscov2exposurealongitudinalstudy AT lerincarles antisarscov2igaandigginhumanmilkaftervaccinationisdependentonvaccinetypeandprevioussarscov2exposurealongitudinalstudy AT martinezcostacecilia antisarscov2igaandigginhumanmilkaftervaccinationisdependentonvaccinetypeandprevioussarscov2exposurealongitudinalstudy AT colladomariacarmen antisarscov2igaandigginhumanmilkaftervaccinationisdependentonvaccinetypeandprevioussarscov2exposurealongitudinalstudy |
_version_ |
1777670178759245824 |